Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study

被引:46
|
作者
Nakayama, Masaaki [1 ,2 ]
Sato, Toshinobu [3 ]
Miyazaki, Mariko
Matsushima, Masato [4 ]
Sato, Hiroshi [5 ]
Taguma, Yoshio [3 ]
Ito, Sadayoshi
机构
[1] Tohoku Univ, Grad Sch Med, Ctr Adv Integrated Renal Sci, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Fukushima Med Univ, Sch Med, Fukushima, Japan
[3] Sendai Shakaihoken Hosp, Kidney Ctr, Sendai, Miyagi, Japan
[4] Jikei Univ, Sch Med, Dept Clin Res, Tokyo, Japan
[5] Tohoku Univ, Grad Sch Pharmacol, Dept Clin Pharmacol, Sendai, Miyagi 9808574, Japan
关键词
cardiovascular disease; chronic kidney disease; hypertensive nephropathy; GENERAL JAPANESE POPULATION; GLOMERULAR-FILTRATION-RATE; MECHANISMS; DYSLIPIDEMIA; PATHOGENESIS; PROTEINURIA; CHILDREN; OUTCOMES; STRESS; STROKE;
D O I
10.1038/hr.2011.96
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
To examine the clinical significance of hypertensive nephropathy (HN) among non-diabetic chronic kidney disease (CKD) patients. The study comprised 2692 CKD patients recruited from 11 outpatient nephrology clinics; these included 1306 patients with primary renal disease (PRD), 458 patients with HN, 283 patients with diabetic nephropathy (DN) and 645 patients with other nephropathies (ONs). All patients fulfilled the criteria of CKD, with a persistent low estimated glomerular filtration rate (eGFR) <60 ml min(-1) per 1.73 m(2) or proteinuria as determined by a urine dipstick test. The risk factors for cardiovascular disease (CVD), such as ischemic heart disease, congestive heart failure and stroke; all-cause mortality; and progression to end-stage renal failure (dialysis induction) were analyzed using a Cox proportional hazards model in each group. During a mean follow-up period of 22.6 months from recruitment, 100 patients were lost to follow-up and 192 patients began chronic dialysis therapy. A total of 115 CVD events occurred (stroke in 37 cases), and 44 patients died. Regarding CVD events and death, there were significant differences in the hazard ratios (HRs) for the groups of patients with different underlying renal diseases as determined by both univariate and multivariate analysis adjusted for confounding factors including estimated glomerular filtration rate: PRD, 1.0 (reference); HN, 3.33 (95% confidence interval, 1.82-6.09); DN, 5.93 (2.80-12.52); and ON, 2.22 (1.22-4.05). However, there were no differences in the hazard ratio for dialysis induction for the groups of patients with different underlying renal diseases. HN is associated with an increased risk of CVD events and death among non-diabetic CKD patients, which highlights the clinical significance of HN. Hypertension Research (2011) 34, 1106-1110; doi:10.1038/hr.2011.96; published online 28 July 2011
引用
收藏
页码:1106 / 1110
页数:5
相关论文
共 50 条
  • [31] Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: Just a coincidence?
    Targher, G.
    Chonchol, M.
    Pichiri, I.
    Zoppini, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (07) : 544 - 551
  • [32] Prevalence of Hyperkalemia in Diabetic and Non-Diabetic Patients with Chronic Kidney Disease: A Nested Case-Control Study
    Loutradis, Charalampos
    Tolika, Panagiota
    Skodra, Alexandra
    Avdelidou, Afroditi
    Sarafidis, Pantelis A.
    AMERICAN JOURNAL OF NEPHROLOGY, 2015, 42 (05) : 351 - 360
  • [33] Oral mucosa and salivary findings in non-diabetic patients with chronic kidney disease
    Marinoski, Jovan
    Bokor-Bratic, Marija
    Mitic, Igor
    Cankovic, Milos
    ARCHIVES OF ORAL BIOLOGY, 2019, 102 : 205 - 211
  • [34] Correlates of Serum Resistin in Elderly, Non-Diabetic Patients with Chronic Kidney Disease
    Marouga, Anna
    Dalamaga, Maria
    Kastania, Anastasia N.
    Antonakos, George
    Thrasyvoulides, Apollon
    Kontelia, Georgia
    Dimas, Claire
    Vlahakos, Demetrios V.
    CLINICAL LABORATORY, 2013, 59 (9-10) : 1121 - 1128
  • [35] Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study
    Bundy, Joshua D.
    Rahman, Mahboob
    Matsushita, Kunihiro
    Jaeger, Byron C.
    Cohen, Jordana B.
    Chen, Jing
    Deo, Rajat
    Dobre, Mirela A.
    Feldman, Harold I.
    Flack, John
    Kallem, Radhakrishna R.
    Lash, James P.
    Seliger, Stephen
    Shafi, Tariq
    Weiner, Shoshana J.
    Wolf, Myles
    Yang, Wei
    Allen, Norrina B.
    Bansal, Nisha
    He, Jiang
    CRIC Study Investigators
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (03): : 601 - 611
  • [36] Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease
    Ivkovic, Vanja
    Bruchfeld, Annette
    CLINICAL KIDNEY JOURNAL, 2024, 17 (04)
  • [37] Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease and Sleep Apnea Syndrome
    Watanabe, Yu
    Tanaka, Akihito
    Furuhashi, Kazuhiro
    Saito, Shoji
    Maruyama, Shoichi
    FRONTIERS IN MEDICINE, 2022, 9
  • [38] Arterial stiffness and increased cardiovascular risk in chronic kidney disease
    Ma, Yuxia
    Zhou, Lin
    Dong, Jinghui
    Zhang, Xiaoshen
    Yan, Shi
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (07) : 1157 - 1164
  • [39] Nonlinear association between proteinuria levels and the risk of cardiovascular disease events and all-cause mortality among chronic kidney disease patients
    Song, Haiying
    Liao, Yuheng
    Hu, Haofei
    Wan, Qijun
    RENAL FAILURE, 2024, 46 (01)
  • [40] Diabetes, Cardiovascular Disease, and Cardiovascular Risk in Patients with Chronic Kidney Disease
    De Lima, Jose J. G.
    Gowdak, Luis Henrique W.
    David-Neto, Elias
    Bortolotto, Luiz A.
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (02) : 159 - 165